CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: VISCOSUPPLEMENTATION MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Single Injection Viscosupplementation
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Three Injection Viscosupplementation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Five Injection Viscosupplementation
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: VISCOSUPPLEMENTATION MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Knee Osteoarthritis
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Knee Osteoarthritis Viscosupplementation Market by Gender
5.2.4.1 Male Market size and forecast, by region
5.2.4.2 Female Market size and forecast, by region
5.3 Hip Osteoarthritis
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Hand Osteoarthritis
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Retail Pharmacies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Online Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: VISCOSUPPLEMENTATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.3.1 North America Knee Osteoarthritis Viscosupplementation Market by Gender
7.2.4 North America Market size and forecast, by Distribution channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Distribution channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Distribution channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Distribution channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.3.1 Europe Knee Osteoarthritis Viscosupplementation Market by Gender
7.3.4 Europe Market size and forecast, by Distribution channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Distribution channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Distribution channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Distribution channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Distribution channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by Distribution channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by Distribution channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.3.1 Asia-Pacific Knee Osteoarthritis Viscosupplementation Market by Gender
7.4.4 Asia-Pacific Market size and forecast, by Distribution channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Distribution channel
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Distribution channel
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Distribution channel
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Distribution channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Distribution channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by Distribution channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.3.1 LAMEA Knee Osteoarthritis Viscosupplementation Market by Gender
7.5.4 LAMEA Market size and forecast, by Distribution channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Distribution channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Distribution channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by Distribution channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by Distribution channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Seikagaku Corporation
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Anika Therapeutics, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 aptissen
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Avanos Medical, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Bioventus
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Chugai Pharmaceutical Corp.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Fidia Farmaceutici S.P.A
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 LG Life Sciences Ltd.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sanofi
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Miravo Healthcare
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
| ※参考情報 関節内補充治療、またはビスコサプリメンテーションは、主に変形性関節症やその他の関節疾患の治療に用いられる医療技術です。関節内にヒアルロン酸やその他の粘弾性物質を注入することで、関節の潤滑性やクッション機能を改善し、疼痛を軽減することを目的とします。この治療法は、特に膝関節に対する治療法として広く用いられていますが、他の関節にも適応されることがあります。 ビスコサプリメンテーションに用いられる主要な物質はヒアルロン酸です。ヒアルロン酸は、体内に自然に存在する多糖類であり、細胞間の水分保持や組織の潤滑性に寄与しています。関節内にヒアルロン酸を注入することで、関節液中のヒアルロン酸濃度が高まり、関節の摩擦を軽減し、運動時の快適性を向上させる効果があります。ヒアルロン酸の分子量や濃度、製剤の特性によって効果が異なるため、さまざまな種類の製品が市販されています。 ビスコサプリメンテーションの主な用途は、変形性関節症の治療です。変形性関節症は、関節の軟骨がすり減っていくことで疼痛や運動制限が生じる病態であり、特に膝関節に多く見られます。この治療法は、特に初期から中期の段階で効果が発揮されることが多く、最近の研究では改善率が高いことも報告されています。さらに、他の関節疾患や外傷後の関節の疼痛軽減にも用いられる場合があります。 この治療法の利点は、比較的侵襲性が低く、手術療法に比べて合併症のリスクが少ない点です。注射による治療のため、一般的に外来で行われ、治療後の回復も早いです。しかし、すべての患者に対して効果があるわけではなく、個々の症状や状態に応じて効果に差が出ることがあります。 さらに、最近ではビスコサプリメンテーションの関連技術も注目されています。例えば、超音波ガイド下での注入技術があります。これにより、より正確にヒアルロン酸を関節腔内に注入することが可能になり、治療効果を高めることが期待されています。また、他の物質と組み合わせたコンビネーション療法の研究も進められており、例えば、鎮痛薬や抗炎症薬を併用することで、より効果的な治療が提供される可能性があります。 ビスコサプリメンテーションは、治療の効果についての議論が続いており、研究者や医療従事者がその有効性を評価し続けています。さまざまな臨床試験が行われ、結果が蓄積されることで、より明確な治療ガイドラインが形成されることが期待されています。 この治療法は、特に加齢に伴って関節疾患に悩む患者にとって有望な選択肢です。手軽に受けられ、合併症が少ないため、生活の質を向上させる可能性があります。今後の研究によって、新たな治療法の登場や既存の治療法の改善が進むことで、より効果的な関節内補充治療が期待されています。医療従事者は、患者一人ひとりにあった治療法を選択し、適切な説明を行うことが求められます。 ビスコサプリメンテーションは、関節治療の非常に重要な一環を成しており、今後の発展が注目される分野です。このような治療法を通じて、多くの患者が痛みから解放され、より快適な生活を送ることができるようになることを期待しています。 |
